Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Living Donors | 10 | 2022 | 647 | 1.620 |
Why?
|
Kidney Transplantation | 14 | 2022 | 4268 | 1.180 |
Why?
|
Nephrectomy | 7 | 2021 | 928 | 0.980 |
Why?
|
Tissue and Organ Harvesting | 5 | 2019 | 372 | 0.880 |
Why?
|
Lymphedema | 6 | 2023 | 526 | 0.720 |
Why?
|
Tissue Donors | 7 | 2022 | 2387 | 0.650 |
Why?
|
Lymphatic Vessels | 4 | 2023 | 356 | 0.580 |
Why?
|
Population Groups | 1 | 2017 | 209 | 0.520 |
Why?
|
Tissue and Organ Procurement | 7 | 2021 | 987 | 0.520 |
Why?
|
Carcinoma, Transitional Cell | 4 | 2023 | 790 | 0.500 |
Why?
|
Pain, Postoperative | 6 | 2024 | 1768 | 0.480 |
Why?
|
Cultural Diversity | 1 | 2017 | 373 | 0.430 |
Why?
|
Kidney Failure, Chronic | 5 | 2017 | 2495 | 0.430 |
Why?
|
Urinary Bladder Neoplasms | 5 | 2023 | 2186 | 0.430 |
Why?
|
Lymph Node Excision | 6 | 2024 | 1267 | 0.390 |
Why?
|
Comprehension | 1 | 2017 | 636 | 0.380 |
Why?
|
Prostatectomy | 4 | 2024 | 1786 | 0.370 |
Why?
|
Analgesics, Opioid | 5 | 2024 | 3837 | 0.320 |
Why?
|
Prostatic Neoplasms | 8 | 2024 | 11097 | 0.300 |
Why?
|
Burnout, Professional | 3 | 2021 | 711 | 0.280 |
Why?
|
Personal Satisfaction | 3 | 2019 | 643 | 0.250 |
Why?
|
Internet | 1 | 2017 | 3114 | 0.240 |
Why?
|
Prostate-Specific Antigen | 3 | 2024 | 2463 | 0.240 |
Why?
|
Lymphocele | 1 | 2024 | 19 | 0.230 |
Why?
|
Mastectomy | 4 | 2021 | 1861 | 0.230 |
Why?
|
Insurance, Health | 1 | 2016 | 2519 | 0.220 |
Why?
|
Motor Vehicles | 2 | 2015 | 280 | 0.210 |
Why?
|
Gastric Bypass | 2 | 2023 | 820 | 0.210 |
Why?
|
Peritoneum | 1 | 2024 | 227 | 0.210 |
Why?
|
Breast Neoplasms | 9 | 2023 | 21178 | 0.200 |
Why?
|
Obesity, Morbid | 2 | 2023 | 1293 | 0.190 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2022 | 4054 | 0.180 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2022 | 195 | 0.180 |
Why?
|
Tissue Transplantation | 1 | 2021 | 128 | 0.180 |
Why?
|
Mammaplasty | 2 | 2021 | 1268 | 0.180 |
Why?
|
Quality of Life | 9 | 2023 | 13485 | 0.180 |
Why?
|
Rectal Diseases | 1 | 2021 | 141 | 0.170 |
Why?
|
Renal Insufficiency | 2 | 2018 | 812 | 0.170 |
Why?
|
Pelvic Floor | 1 | 2021 | 138 | 0.170 |
Why?
|
Colonic Diseases | 1 | 2021 | 204 | 0.170 |
Why?
|
Video Recording | 2 | 2015 | 977 | 0.170 |
Why?
|
Liver Transplantation | 2 | 2022 | 2416 | 0.160 |
Why?
|
Pelvis | 1 | 2024 | 736 | 0.160 |
Why?
|
Penile Neoplasms | 1 | 2021 | 158 | 0.160 |
Why?
|
Lipectomy | 1 | 2020 | 114 | 0.160 |
Why?
|
Lymphatic Metastasis | 3 | 2022 | 2900 | 0.160 |
Why?
|
Organ Transplantation | 2 | 2021 | 1173 | 0.160 |
Why?
|
Acupuncture Therapy | 1 | 2023 | 485 | 0.150 |
Why?
|
Humans | 65 | 2024 | 767040 | 0.150 |
Why?
|
Cystectomy | 4 | 2023 | 603 | 0.150 |
Why?
|
Surgical Procedures, Operative | 2 | 2022 | 1931 | 0.150 |
Why?
|
Tracheotomy | 1 | 2019 | 174 | 0.150 |
Why?
|
Surgery Department, Hospital | 1 | 2019 | 170 | 0.150 |
Why?
|
Substance Abuse, Intravenous | 1 | 2022 | 530 | 0.140 |
Why?
|
Blood Loss, Surgical | 1 | 2021 | 642 | 0.140 |
Why?
|
Quality-Adjusted Life Years | 1 | 2024 | 1741 | 0.140 |
Why?
|
Random Allocation | 2 | 2019 | 2394 | 0.140 |
Why?
|
Gastroplasty | 1 | 2019 | 155 | 0.140 |
Why?
|
Fear | 2 | 2018 | 1496 | 0.140 |
Why?
|
Waiting Lists | 2 | 2022 | 778 | 0.140 |
Why?
|
Urinary Incontinence | 1 | 2021 | 490 | 0.140 |
Why?
|
Muscle Strength | 1 | 2021 | 640 | 0.130 |
Why?
|
End Stage Liver Disease | 1 | 2021 | 369 | 0.130 |
Why?
|
Digestive System Surgical Procedures | 1 | 2021 | 584 | 0.130 |
Why?
|
Urinary Bladder | 4 | 2023 | 1155 | 0.130 |
Why?
|
Postoperative Complications | 4 | 2024 | 15824 | 0.130 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2022 | 3552 | 0.130 |
Why?
|
Drug Prescriptions | 2 | 2024 | 1664 | 0.130 |
Why?
|
Models, Educational | 1 | 2019 | 375 | 0.130 |
Why?
|
Patient Discharge | 3 | 2024 | 3467 | 0.130 |
Why?
|
Decision Making | 3 | 2019 | 3951 | 0.130 |
Why?
|
Drug Utilization | 1 | 2022 | 1190 | 0.130 |
Why?
|
Practice Guidelines as Topic | 2 | 2024 | 7435 | 0.130 |
Why?
|
Subthalamic Nucleus | 1 | 2018 | 203 | 0.130 |
Why?
|
Axilla | 3 | 2023 | 622 | 0.120 |
Why?
|
Surgical Flaps | 1 | 2024 | 1680 | 0.120 |
Why?
|
Follow-Up Studies | 8 | 2021 | 39317 | 0.120 |
Why?
|
Male | 34 | 2024 | 364203 | 0.120 |
Why?
|
Middle Aged | 28 | 2024 | 223233 | 0.120 |
Why?
|
Hospitals, Teaching | 1 | 2019 | 1156 | 0.110 |
Why?
|
Automobile Driving | 1 | 2019 | 442 | 0.110 |
Why?
|
Decision Support Techniques | 1 | 2024 | 2006 | 0.110 |
Why?
|
Adult | 26 | 2024 | 223317 | 0.110 |
Why?
|
Hepatitis C, Chronic | 1 | 2022 | 1032 | 0.110 |
Why?
|
Emotions | 3 | 2023 | 2760 | 0.110 |
Why?
|
Thoracic Surgery | 1 | 2020 | 727 | 0.110 |
Why?
|
Rectal Neoplasms | 1 | 2023 | 1183 | 0.110 |
Why?
|
Retrospective Studies | 17 | 2024 | 81659 | 0.110 |
Why?
|
Aged | 23 | 2024 | 171319 | 0.110 |
Why?
|
Brachytherapy | 1 | 2021 | 1220 | 0.110 |
Why?
|
Public Opinion | 1 | 2017 | 484 | 0.110 |
Why?
|
Program Development | 1 | 2019 | 1298 | 0.100 |
Why?
|
Health Expenditures | 2 | 2016 | 2390 | 0.100 |
Why?
|
Costs and Cost Analysis | 2 | 2016 | 1666 | 0.100 |
Why?
|
Body Image | 1 | 2018 | 646 | 0.100 |
Why?
|
Female | 32 | 2024 | 396660 | 0.100 |
Why?
|
Attitude to Health | 2 | 2020 | 2023 | 0.100 |
Why?
|
Laparoscopy | 1 | 2024 | 2037 | 0.100 |
Why?
|
Fatigue | 1 | 2019 | 1556 | 0.100 |
Why?
|
Adenoma | 1 | 2022 | 2155 | 0.100 |
Why?
|
Hepatitis C | 1 | 2022 | 1594 | 0.100 |
Why?
|
Consensus | 1 | 2022 | 3207 | 0.100 |
Why?
|
Bariatric Surgery | 1 | 2022 | 998 | 0.100 |
Why?
|
Lymphography | 2 | 2022 | 189 | 0.090 |
Why?
|
Emergency Service, Hospital | 2 | 2021 | 7871 | 0.090 |
Why?
|
Cost-Benefit Analysis | 1 | 2024 | 5537 | 0.090 |
Why?
|
Alcoholism | 1 | 2022 | 1980 | 0.090 |
Why?
|
Massachusetts | 3 | 2019 | 8890 | 0.090 |
Why?
|
Adolescent Behavior | 1 | 2019 | 1188 | 0.090 |
Why?
|
Indocyanine Green | 2 | 2023 | 237 | 0.090 |
Why?
|
Internship and Residency | 2 | 2021 | 5947 | 0.090 |
Why?
|
Affect | 1 | 2018 | 1494 | 0.080 |
Why?
|
Deep Brain Stimulation | 1 | 2018 | 850 | 0.080 |
Why?
|
Cost of Illness | 1 | 2019 | 1951 | 0.080 |
Why?
|
Early Detection of Cancer | 1 | 2024 | 3236 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 2764 | 0.080 |
Why?
|
Patient Preference | 1 | 2017 | 947 | 0.080 |
Why?
|
Prognosis | 6 | 2022 | 29963 | 0.080 |
Why?
|
Treatment Outcome | 10 | 2023 | 65295 | 0.080 |
Why?
|
Arm | 2 | 2023 | 591 | 0.080 |
Why?
|
Gastrectomy | 2 | 2023 | 693 | 0.070 |
Why?
|
Upper Extremity | 2 | 2023 | 684 | 0.070 |
Why?
|
Veterans | 1 | 2021 | 2666 | 0.070 |
Why?
|
Health Promotion | 2 | 2015 | 2210 | 0.070 |
Why?
|
Opioid-Related Disorders | 1 | 2022 | 2188 | 0.070 |
Why?
|
Altruism | 2 | 2021 | 211 | 0.070 |
Why?
|
Prevalence | 2 | 2022 | 15851 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3232 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2019 | 2355 | 0.060 |
Why?
|
Aftercare | 2 | 2022 | 915 | 0.060 |
Why?
|
Patient Selection | 1 | 2017 | 4256 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 4282 | 0.060 |
Why?
|
Parkinson Disease | 1 | 2018 | 2886 | 0.060 |
Why?
|
Neoplasm Invasiveness | 2 | 2022 | 3611 | 0.060 |
Why?
|
Workload | 2 | 2020 | 849 | 0.060 |
Why?
|
Neoplasm Staging | 3 | 2023 | 11217 | 0.060 |
Why?
|
Pilot Projects | 3 | 2023 | 8732 | 0.050 |
Why?
|
Prostate | 2 | 2022 | 1761 | 0.050 |
Why?
|
Biomedical Research | 1 | 2019 | 3464 | 0.050 |
Why?
|
Adolescent | 5 | 2019 | 89046 | 0.050 |
Why?
|
United States | 6 | 2024 | 72971 | 0.050 |
Why?
|
Administration, Intravesical | 1 | 2022 | 88 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6966 | 0.050 |
Why?
|
Young Adult | 7 | 2020 | 59980 | 0.050 |
Why?
|
Registries | 2 | 2016 | 8351 | 0.050 |
Why?
|
Time Factors | 3 | 2021 | 40154 | 0.050 |
Why?
|
Epigastric Arteries | 1 | 2021 | 93 | 0.050 |
Why?
|
Lymph Nodes | 2 | 2023 | 3468 | 0.050 |
Why?
|
Inguinal Canal | 1 | 2021 | 71 | 0.050 |
Why?
|
Lymphatic System | 1 | 2022 | 250 | 0.040 |
Why?
|
Marital Status | 1 | 2022 | 426 | 0.040 |
Why?
|
Donor Selection | 1 | 2022 | 242 | 0.040 |
Why?
|
Coloring Agents | 1 | 2022 | 565 | 0.040 |
Why?
|
BCG Vaccine | 1 | 2022 | 381 | 0.040 |
Why?
|
Accreditation | 1 | 2023 | 477 | 0.040 |
Why?
|
Religion and Medicine | 1 | 2021 | 161 | 0.040 |
Why?
|
Preoperative Period | 1 | 2021 | 564 | 0.040 |
Why?
|
Physical Endurance | 1 | 2021 | 369 | 0.040 |
Why?
|
Attitude to Death | 1 | 2021 | 400 | 0.040 |
Why?
|
New England | 1 | 2021 | 1058 | 0.040 |
Why?
|
Brain Death | 1 | 2021 | 360 | 0.040 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2019 | 193 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 998 | 0.040 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2022 | 1788 | 0.040 |
Why?
|
Attitude | 1 | 2022 | 769 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2022 | 2850 | 0.030 |
Why?
|
Muscles | 1 | 2022 | 1576 | 0.030 |
Why?
|
Watchful Waiting | 1 | 2021 | 492 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11872 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 8535 | 0.030 |
Why?
|
SEER Program | 1 | 2022 | 1444 | 0.030 |
Why?
|
Job Satisfaction | 1 | 2020 | 548 | 0.030 |
Why?
|
Death | 1 | 2021 | 685 | 0.030 |
Why?
|
Incidence | 3 | 2021 | 21526 | 0.030 |
Why?
|
Risk Factors | 5 | 2023 | 74886 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2022 | 1271 | 0.030 |
Why?
|
Organ Size | 1 | 2021 | 2264 | 0.030 |
Why?
|
Automobile Driver Examination | 1 | 2015 | 25 | 0.030 |
Why?
|
Kidney | 2 | 2022 | 7063 | 0.030 |
Why?
|
Efficiency | 1 | 2019 | 479 | 0.030 |
Why?
|
Survival Rate | 2 | 2022 | 12823 | 0.030 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2019 | 364 | 0.030 |
Why?
|
Chronic Disease | 2 | 2020 | 9362 | 0.030 |
Why?
|
Hepacivirus | 1 | 2022 | 1342 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2021 | 1308 | 0.030 |
Why?
|
Leg | 1 | 2019 | 1087 | 0.030 |
Why?
|
Goals | 1 | 2019 | 717 | 0.030 |
Why?
|
Ultrasonography, Interventional | 1 | 2022 | 1523 | 0.030 |
Why?
|
Rhode Island | 1 | 2014 | 352 | 0.030 |
Why?
|
Androgen Antagonists | 1 | 2022 | 1412 | 0.030 |
Why?
|
Perioperative Care | 1 | 2021 | 1043 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2019 | 1443 | 0.030 |
Why?
|
Employment | 1 | 2019 | 1110 | 0.030 |
Why?
|
Biopsy | 1 | 2024 | 6777 | 0.020 |
Why?
|
Minority Groups | 1 | 2019 | 1214 | 0.020 |
Why?
|
Trust | 1 | 2017 | 532 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2019 | 2741 | 0.020 |
Why?
|
Culture | 1 | 2014 | 622 | 0.020 |
Why?
|
Program Evaluation | 1 | 2019 | 2505 | 0.020 |
Why?
|
Operating Rooms | 1 | 2017 | 790 | 0.020 |
Why?
|
Informed Consent | 1 | 2017 | 1010 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2022 | 2902 | 0.020 |
Why?
|
Graft Survival | 1 | 2021 | 3896 | 0.020 |
Why?
|
Aspirin | 1 | 2021 | 3135 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3070 | 0.020 |
Why?
|
Age Distribution | 1 | 2015 | 2870 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2022 | 3207 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2017 | 4838 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2021 | 2330 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3883 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 59548 | 0.020 |
Why?
|
Mass Screening | 1 | 2024 | 5456 | 0.020 |
Why?
|
Prospective Studies | 3 | 2019 | 54886 | 0.020 |
Why?
|
Cytokines | 1 | 2023 | 7446 | 0.020 |
Why?
|
Health Education | 1 | 2014 | 1058 | 0.020 |
Why?
|
Weight Loss | 1 | 2019 | 2716 | 0.020 |
Why?
|
Databases, Factual | 1 | 2023 | 8068 | 0.020 |
Why?
|
Genetic Testing | 1 | 2020 | 3591 | 0.020 |
Why?
|
Societies, Medical | 1 | 2019 | 3964 | 0.020 |
Why?
|
Reference Values | 1 | 2014 | 4918 | 0.020 |
Why?
|
Risk Assessment | 2 | 2021 | 24299 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36582 | 0.020 |
Why?
|
Curriculum | 1 | 2019 | 3786 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2021 | 4357 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8048 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15424 | 0.010 |
Why?
|
Cohort Studies | 2 | 2019 | 41718 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9410 | 0.010 |
Why?
|
Psychometrics | 1 | 2014 | 3060 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15925 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7848 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14766 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9360 | 0.010 |
Why?
|
Self Report | 1 | 2014 | 3773 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9660 | 0.010 |
Why?
|
Depression | 1 | 2020 | 8234 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8736 | 0.010 |
Why?
|
Sex Factors | 1 | 2014 | 10622 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22254 | 0.010 |
Why?
|
Anxiety | 1 | 2014 | 4670 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2014 | 4526 | 0.010 |
Why?
|
Age Factors | 1 | 2014 | 18401 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2014 | 20169 | 0.010 |
Why?
|
Mice | 1 | 2022 | 81912 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2014 | 26325 | 0.010 |
Why?
|
Animals | 1 | 2022 | 168965 | 0.010 |
Why?
|
Concepts
(246)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(79)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_